Fundz

Coya Therapeutics Secures $23 Million in Public Offering

PUBLIC · COYAOct 27, 2025

Amount Raised

$23 Million

Round Type

Post-IPO Equity

HoustonBiotechnology

Investors

Lucid Capital Markets, LLC

Description

On October 23, 2025, Coya Therapeutics, Inc. entered into an Underwriting Agreement for an underwritten public offering of common stock. The offering involves 4,181,818 shares at an offering price of $5.50 per share. The expected gross proceeds from the offering are approximately $23 million

Quick answer

Coya Therapeutics raised $23 Million in a Post-IPO Equity round, dated October 27, 2025. Investors: Lucid Capital Markets, LLC. Coya Therapeutics is based in Houston, Texas, United States.

How much did Coya Therapeutics raise?
Coya Therapeutics raised $23 Million in a Post-IPO Equity round on October 27, 2025.
Who invested in Coya Therapeutics?
Lucid Capital Markets, LLC is named as investors in this round.
What does Coya Therapeutics do?
Coya Therapeutics, Inc. (Nasdaq: COYA) is a clinical-stage biotechnology company developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells (“Tregs”) to target..
Where is Coya Therapeutics based and how big is it?
Coya Therapeutics is based in Houston, Texas, United States.
Who are the decision-makers at Coya Therapeutics?
Fundz holds 2 contacts at Coya Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Coya Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Allegria Therapeutics raised $5.1M (Seed) on December 11, 2025.
  • Zegenex raised $215K (Pre-Seed) on December 11, 2025.
  • Disco Pharmaceuticals raised $42M (Seed) on December 11, 2025.
  • Valinor raised $13M (Funding Round) on December 11, 2025.
  • Celtic Renewables raised $8.3M (Funding Round) on December 11, 2025.
  • Subsense raised $10M (Funding Round) on December 11, 2025.

Who to call at Coya Therapeutics, and when

A new round usually means Coya Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Coya Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Coya Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Coya Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Coya Therapeutics

Location

Houston, Texas, United States

About

Coya Therapeutics, Inc. (Nasdaq: COYA) is a clinical-stage biotechnology company developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells (“Tregs”) to target systemic inflammation and neuroinflammation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Coya Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts8 people are listed at Coya Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Coya Therapeutics's next move

See what Strategic adds

Coya Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.